132 related articles for article (PubMed ID: 2280824)
21. Vasomotor effects of noradrenaline, acetylcholine, histamine, 5-hydroxytryptamine and bradykinin on snake (Trimeresurus flavoviridis) basilar arteries.
Yoshinaga N; Okuno T; Watanabe Y; Matsumoto T; Shiraishi M; Obi T; Yabuki A; Miyamoto A
Comp Biochem Physiol C Toxicol Pharmacol; 2007 Nov; 146(4):478-83. PubMed ID: 17604230
[TBL] [Abstract][Full Text] [Related]
22. Alpha-trinositol blocks the inhibitory effects of NPY on dilatation to forskolin but not the adenylyl cyclase activity induced by NPY or forskolin in guinea-pig cerebral vessels.
You J; Jansen I; Zhang W; Edvinsson L
Neuropeptides; 1994 Nov; 27(5):259-68. PubMed ID: 7862258
[TBL] [Abstract][Full Text] [Related]
23. Vasomotor effects of noradrenaline, 5-hydroxytryptamine, angiotensin II, bradykinin, histamine, and acetylcholine on the bat (Rhinolophus ferrumequinum) basilar artery.
Islam MZ; Kojima S; Sameshima M; Obi T; Yamazaki-Himeno E; Shiraishi M; Miyamoto A
Comp Biochem Physiol C Toxicol Pharmacol; 2021 Dec; 250():109190. PubMed ID: 34536573
[TBL] [Abstract][Full Text] [Related]
24. D-myo inositol 1,2,6, triphosphate (alpha-trinositol, pp56): selective antagonist at neuropeptide Y (NPY) Y-receptors or selective inhibitor of phosphatidylinositol cell signaling?
Bell D; McDermott BJ
Gen Pharmacol; 1998 Nov; 31(5):689-96. PubMed ID: 9809464
[TBL] [Abstract][Full Text] [Related]
25. Characterization of neuropeptide Y receptors mediating contraction, potentiation and inhibition of relaxation.
Nilsson T; You J; Sun X; Hedner T; Edvinsson L
Blood Press; 1996 May; 5(3):164-9. PubMed ID: 8790927
[TBL] [Abstract][Full Text] [Related]
26. Is PP56 (D-myo-inositol-1,2,6-trisphosphate) an antagonist at neuropeptide Y receptors?
Feth F; Erdbrügger W; Rascher W; Michel MC
Life Sci; 1993; 52(23):1835-44. PubMed ID: 8388981
[TBL] [Abstract][Full Text] [Related]
27. Regional involvement of an endothelium-derived contractile factor in the vasoactive actions of neuropeptide Y in bovine isolated retinal arteries.
Prieto D; Simonsen U; Nyborg NC
Br J Pharmacol; 1995 Nov; 116(6):2729-37. PubMed ID: 8590997
[TBL] [Abstract][Full Text] [Related]
28. Relaxing effects of vasoactive intestinal peptide (VIP) on the contractile actions of endothelin-3, histamine, and acetylcholine in isolated guinea pig tracheal smooth muscle with or without epithelium.
Uzuner K; Tunçel N; Aydin Y
Peptides; 1996; 17(2):299-303. PubMed ID: 8801537
[TBL] [Abstract][Full Text] [Related]
29. Potentiation by neuropeptide Y of vasoconstriction in rat resistance arteries.
Andriantsitohaina R; Stoclet JC
Br J Pharmacol; 1988 Oct; 95(2):419-28. PubMed ID: 2465806
[TBL] [Abstract][Full Text] [Related]
30. Innervation of human omental arteries and veins and vasomotor response to noradrenaline, neuropeptide Y, substance P and vasoactive intestinal peptide.
Edvinsson L; Håkanson R; Steen S; Sundler F; Uddman R; Wahlestedt C
Regul Pept; 1985 Sep; 12(1):67-79. PubMed ID: 2416012
[TBL] [Abstract][Full Text] [Related]
31. Innervation of the human middle meningeal artery: immunohistochemistry, ultrastructure, and role of endothelium for vasomotility.
Edvinsson L; Gulbenkian S; Barroso CP; Cunha e Sá M; Polak JM; Mortensen A; Jørgensen L; Jansen-Olesen I
Peptides; 1998; 19(7):1213-25. PubMed ID: 9786171
[TBL] [Abstract][Full Text] [Related]
32. Neuropeptide Y (NPY) in the orbital arteries of the rabbit. Immunocytochemistry and vasomotor activity.
Elsås T; Uddman R; Junping Y; Edvinsson L
Acta Ophthalmol Scand; 1995 Dec; 73(6):517-20. PubMed ID: 9019375
[TBL] [Abstract][Full Text] [Related]
33. No effect of D-myo-inositol-1,2,6-triphosphate on vasoconstriction evoked by neuropeptide Y and non-adrenergic sympathetic nerve stimulation.
Pernow J; Modin A; Lundberg JM
Eur J Pharmacol; 1992 Nov; 222(1):171-4. PubMed ID: 1468494
[TBL] [Abstract][Full Text] [Related]
34. D-myo-inositol-1,2,6-trisphosphate is a selective antagonist of neuropeptide Y-induced pressor responses in the pithed rat.
Sun XY; Dahlöf C; Edvinsson L; Hedner T
Eur J Pharmacol; 1991 Nov; 204(3):281-6. PubMed ID: 1773830
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological characteristics of the canine cerebrovascular constriction produced by neuropeptide Y.
Uneyama H; Tanaka Y; Iwata S; Ishiguro T; Nakayama K
Biol Pharm Bull; 1995 Apr; 18(4):501-6. PubMed ID: 7655416
[TBL] [Abstract][Full Text] [Related]
36. Renovascular and tubular effects of neuropeptide Y are discriminated by PP56 (D-myo-inositol 1,2,6-triphosphate) in anaesthetized rats.
Bischoff A; Stickan-Verfürth M; Michel MC
Pflugers Arch; 1997 May; 434(1):57-62. PubMed ID: 9094256
[TBL] [Abstract][Full Text] [Related]
37. Effects of chronic diabetes on vascular responses of basilar artery and aorta from rabbits with alloxan-induced diabetes.
Abiru T; Kamata K; Kasuya Y
Res Commun Chem Pathol Pharmacol; 1991 Oct; 74(1):71-87. PubMed ID: 1801104
[TBL] [Abstract][Full Text] [Related]
38. Characteristics of relaxation induced by calcitonin gene-related peptide in contracted rabbit basilar artery.
Sutter B; Suzuki S; Kassell NF; Lee KS
J Neurosurg; 1995 Jan; 82(1):91-6. PubMed ID: 7815140
[TBL] [Abstract][Full Text] [Related]
39. Neuropeptide Y potentiates noradrenaline-evoked vasoconstriction by an intracellular calcium-dependent mechanism.
Fallgren B; Arlock P; Edvinsson L
J Auton Nerv Syst; 1993; 44(2-3):151-9. PubMed ID: 8227954
[TBL] [Abstract][Full Text] [Related]
40. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
